Gilead Sciences (GILD)

R&D Expense Growth

28.57%

Quarterly · Period ending:

GILD logo

GILD R&D Expense Growth

Latest reported28.57%
GILD Quarterly R&D Growth (QoQ) (0.00% → 28.57%)
High-resolution chart · PNG

GILD r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
28.5714%
-13.3838%
17.682%
-9.725%
8.1218%
-15.9659%
17.6344%
3.2568%
-11.1184%
7.9545%
-3.3631%
3.5537%
-2.7643%
225.6076%
-200.2611%
4.265%
-71.5833%
91.3172%
84.1054%
0.8242%
3.5071%
-33.1432%
36.2694%
-10.8545%
29.3825%
-47.1301%
84.3689%
3.5176%
-5.8657%
-45.7949%
107.6677%
-21.2248%
27.2145%
-18.5217%
45.7541%
-8.6806%
-7.1966%
-22.9305%
5.872%
-23.1132%
17.3123%
67.107%
1.8843%
-9.1687%
17.5287%
-33.3737%
65.8146%
7.8767%
-1.8487%
7.7942%
1.0497%
4.2645%
5.279%
13.1859%
-5.6183%
17.5617%
-13.5237%
13.916%
38.6705%
2.7135%
10.9874%
-35.2159%
70.4392%
-0.2709%
5.6717%
-8.755%
-11.1952%
11.6778%
28.0005%
-6.4816%
7.3385%
6.5254%
13.6773%
-15.8935%
31.556%
3.2561%
4.49%
16.5472%
19.6292%
3.0585%
2.4163%
28.5575%
-12.7705%
32.0502%
-15.2441%
0.3905%
42.59%
7.8019%
-22.0377%
9.9086%
48.0461%
-16.9398%
5.2941%
17.4925%
-0.914%
14.5441%
-8.0557%
-24.7685%
-2.4646%
3.7434%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.